Related Experiment Videos
Validity of stereotactic biopsy as a diagnostic tool
F Colombo1, L Casentini, M Zanusso
1Department of Neurosurgery, City Hospital, Vicenza, Italy.
Acta Neurochirurgica. Supplementum
|January 1, 1988
Summary
Stereotactic biopsy accurately diagnosed 83% of intracranial lesions. Diagnostic success varied with lesion characteristics, being lower for complex or ill-defined tumors.
Area of Science:
- Neurosurgery
- Neuroradiology
- Oncology
Background:
- Stereotactic biopsy is a crucial diagnostic tool for intracranial lesions.
- Accurate preoperative diagnosis impacts treatment planning and patient outcomes.
Purpose of the Study:
- To evaluate the diagnostic yield of stereotactic biopsy for intracranial lesions.
- To identify factors influencing diagnostic accuracy.
Main Methods:
- Retrospective analysis of 254 patients undergoing stereotactic biopsy between 1978 and 1986.
- Computed tomography (CT) used for target localization.
- Biopsy performed using cup microforceps or sliding cannula.
Main Results:
- Definitive diagnosis was achieved in 83% of patients (211/254).
- Operative mortality was low (2 cases).
- Diagnostic success was highest for solid, homogeneous tumors with clear borders; lower for heterogeneous, necrotic, cystic, or non-classifiable lesions.
Conclusions:
- Stereotactic biopsy is a safe and effective method for diagnosing intracranial lesions.
- Tumor characteristics, particularly CT appearance, significantly influence diagnostic accuracy.
- Consider lesion variability when planning stereotactic biopsy procedures.